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Summary
The crystal structure of Aspergillus fumigatus cyclo-
philin (Asp f 11) was solved by the multiwavelength
anomalous dispersion method and was refined to
a resolution of 1.85 A˚ with R and Rfree values of
18.9% and 21.4%, respectively. Many cyclophilin struc-
tures have been solved to date, all showing the same
monomeric conformation. In contrast, the structure
of A. fumigatus cyclophilin reveals dimerization by
3D domain swapping and represents one of the first
proteins with a swapped central domain. The do-
main-swapped element consists of two b strands
and a subsequent loop carrying a conserved trypto-
phan. The tryptophan binds into the active site, inacti-
vating cis-trans isomerization. This might be a means
of biological regulation. The two hinge loops leave the
protein prone to misfolding. In this context, alternative
forms of 3D domain swapping that can lead to N- or C-
terminally swapped dimers, oligomers, and aggre-
gates are discussed.
Introduction
Cyclophilins (CyPs) constitute a family of cytosolic pro-
teins involved in many biological processes. CyP is an
enzyme that catalyzes the peptidyl-prolyl cis-trans
isomerization (PPIase) (Fischer et al., 1989; Takahashi
et al., 1989). Belonging to the family of immunophilins,
CyP binds the immunosuppressive drug cyclosporin A
(CsA) (Handschumacher et al., 1984). The complex of
CyP with CsA binds and inhibits the protein phospha-
tase calcineurin (Liu et al., 1991), thus suppressing sig-
nal transduction in T cells (Jain et al., 1993). Therefore,
CsA is one of the most important immunosuppressant
drugs used for prevention of graft rejection after trans-
plant surgery (Borel, 1990). CyPs are also assumed to
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Ernest-Ansermet 30, 1211 Gene`ve 4, Switzerland.participate in other biological functions, such as cell sur-
face recognition (Anderson et al., 1993) and heat shock
response (Sykes et al., 1993).
CyPs exist abundantly and ubiquitously in a broad
range of organisms (Hunter, 1998). They have also
been isolated as IgE binding proteins from several fungi
(Flu¨ckiger et al., 2002; Horner et al., 1995; Lindborg et al.,
1999), including CyP from the mold Aspergillus fumiga-
tus (Asp f 11) (Crameri, 1999). A. fumigatus is the etio-
logic agent identified in 80% of Aspergillus-related hu-
man diseases. The ubiquitous mold is considered as
an opportunistic pathogen associated with an impres-
sive list of pulmonary and allergic complications in hu-
mans and animals (Bardana, 1981). The ability of the ac-
tive Asp f 11 to act as an allergen in vivo was shown by
positive skin reactions of A. fumigatus-sensitized indi-
viduals (Flu¨ckiger et al., 2002). Crossreactivity between
Asp f 11 and other CyPs from Malassezia sympodialis,
Candida albicans, Saccharomyces cerevisiae, and
Homo sapiens were shown by Western blot analysis
and inhibition ELISA (Flu¨ckiger et al., 2002).
Several structures of CyPs have been solved (Table 1).
Despite the fact that crystals were grown under different
conditions, such as PEG and ammonium sulfate, result-
ing in different unit cell dimensions and space groups, all
of them are monomeric (Table 1). They share the same
fold consisting of a b barrel with eight antiparallel
b strands and two a helices covering the bottom and
top of the barrel. In contrast, the crystal structure of
Asp f 11, presented here, reveals a dimer formed by
3D domain swapping of two central b strands and a sub-
sequent loop. 3D domain swapping is the event by
which a monomer exchanges part of its structure with
identical monomers to form an oligomer, where each
subunit has a similar structure to the monomer (Rous-
seau et al., 2003).
In the present work, inhibition of cis-trans isomeriza-
tion activity as a consequence of domain swapping
and as a potential way of functional regulation is dis-
cussed. Furthermore, alternative forms of 3D domain
swapping leading to misfolded dimers and oligomers
are addressed.
Results and Discussion
Structure Determination
Initial crystals of the original protein, which contained
a noncleavable His tag and a linker region at the N termi-
nus, diffracted to about 3.0 A˚ resolution on a home
source. Cocrystallization with the dipeptide Ala-Pro im-
proved the resolution by about 0.5 A˚. Removal of the His
tag and linker improved the resolution by a further 0.5 A˚.
The final protein crystals, cocrystallized with Ala-Pro,
diffracted to about 1.8 A˚ resolution at the Swiss Light
Source (Villigen, Switzerland), where all relevant data-
sets were collected.
Considering the high homology to human CyPA (56%
sequence identity), the structure was expected to be
solvable by molecular replacement. Surprisingly, no so-
lution was found, neither with AMORE (Navaza, 1994)
Structure
186Table 1. Structures of Cyclophilins that Have Been Solved to Date
Protein (Ligand) Resolution (A˚)
R Factors,
R/Rfree (%)
Space
Group
Quaternary
Structure PDB Code Reference
Human CyPA 1.63 18.0/— P212121 monomer 2CPL (Ke, 1992)
Human CyPB (CsA) 1.85 16.0/— P212121 monomer 1CYN (Mikol et al., 1994)
Human CyPH (U4/U6 SnRNP) 2.00 19.5/21.2 P1211 monomer 1MZW (Reidt et al., 2003)
Human Nucl CyP20 2.00 17.0/22.4 P212121 monomer 1QOI (Reidt et al., 2000)
Human CyPJ 2.60 17.5/23.6 P3121 monomer 1XYH (Huang et al., 2005)
E. coli CyP 2.10 16.0/— C2221 monomer 2NUL (unpublished data)
E. coli CyPB 1.80 20.1/22.5 P3221 monomer 1J2A (Konno et al., 2004)
Murine CyPC (CsA) 1.64 19.7/— P1211 monomer 2RMC (Ke et al., 1993b)
B. malayi CyP1 1.95 19.9/23.3 P41212 monomer 1A58 (Taylor et al., 1998)
P. falciparum CyP19 (CsA) 2.10 15.0/19.0 P1 monomer 1QNG (Peterson et al., 2000)
C. elegans CyP3 1.80 21.5/28.6 P41212 monomer 1DYW (Dornan et al., 1999)
C. elegans CyP5 1.75 18.2/25.0 P61 monomer 1H0P (Picken et al., 2002)
Bovine CyP40 1.80 17.8/25.6 C121 monomer 1IHG (Taylor et al., 2001)
S. cerevisiae CyPA 1.90 19.9/21.6 P1 monomer 1IST (unpublished data)
M. tuberculosis CyPA 2.60 21.2/22.9 P31 monomer 1W74 (Henriksson et al., 2004)
A. fumigatus CyP; Asp f 11 1.85 18.9/21.4 P3121 3D d.s. dimer 2C3B (present work)
One representative of each protein is listed (unligated, if available).A. fumigatusCyP (Asp f 11) is the only one forming a 3D domain swapping (3D
d.s.) dimer.nor with MOLREP (Vagin and Teplyakov, 1997). There-
fore, selenomethionylated protein was expressed and
crystallized in order to perform a multiwavelength anom-
alous dispersion (MAD) experiment. The X-ray structure
was solved by MAD phasing and refined against native
data to a resolution of 1.85 A˚ with R and Rfree values of
18.9% and 21.4%, respectively. A total of 90.9% of the
residues are in the most favored regions of the Rama-
chandran plot, with those remaining located in the addi-
tional allowed regions. Data collection, phasing, and re-
finement statistics are shown in Table 2.
There are two monomers per asymmetric unit. The fi-
nal model reveals an intertwined dimer consisting of
chain A and B. Both chains run from the start methionineto the last residue (Leu171) of the protein. The hinge re-
gion (aa 126–129) between the two subunits can be
traced unambiguously within a good quality electron
density map resulting from solvent flattening done with-
out NCS averaging. Correlation coefficient values higher
than 0.7 resulting from the real space correlation analy-
sis indicate the correctness of the tracing. Two loops are
missing in the final model: Phe70 to Phe91 and Asn105
to Ser113 in chain A and Asp69 to His95 and Asn105
to Gly112 in chain B. These loops are highly flexible re-
sulting in a poor electron density. In chain A, the last res-
idue of the thrombin cleavage site (Ser0) is also visible;
123 water molecules and 2 sulfate ions have been
added. They are all well defined in the electron density.Table 2. Data Collection, Phasing, and Refinement Statistics
Native Se (Inflection) Se (Peak) Se (Remote)
Data collection
Wavelength (A˚) 0.99990 0.97988 0.97894 0.97128
Unit cell axes a = b, c (A˚) 64.83, 156.29 64.85, 157.01 64.86, 156.83 64.99, 157.37
Resolution (A˚) 45.6–1.85 (1.92–1.85) 38.3–2.05 (2.12–2.05) 38.3–2.05 (2.12–2.05) 38.4–2.27 (2.35–2.27)
Unique reflections 33,079 46,229 46,153 34,063
Redundancy 5.9 5.6 5.6 5.0
Completeness (%) 99.1 (99.9) 99.7 (99.6) 99.5 (99.7) 99.0 (93.2)
Rsym (%) 8.7 (48.8) 4.5 (23.5) 4.7 (24.2) 6.1 (28.8)
Average I/s 19.2 (2.6) 20.2 (4.8) 20.5 (5.0) 17.4 (3.3)
MAD Phasing
Phasing power (iso/ano) —/0.66 0.96/0.82 0.14/0.48
Rcullis (iso/ano) —/0.94 0.75/0.78 1.00/0.90
FOM (SHARP/RESOLVE) 0.32/0.60
Refinement statistics
Resolution (A˚) 45.6–1.85
Number of reflections 33,035
Number of atoms 2308
Rcryst (%) 18.9
Rfree (%) 21.4
Mean B factor (A˚2): All atoms 43.7
Main chain atoms (chain A/B) 40.8/40.9
Side chain atoms (chain A/B) 46.1/46.2
Solvent atoms 46.0
Rmsd bond lengths (A˚) 0.014
Rmsd bond angles (º) 1.95
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Ala-Pro is not visible in the electron density, neither the
active site, nor on the surface. Due to dimerization, the
active site is not accessible. Therefore, Ala-Pro cannot
bind, despite its affinity to CyP. The Kd of Ala-Pro for Asp
f 11 is not known, but it is most probably comparable to
the Kd of other CyPs; Asp f 11 shows comparable activ-
ities to other CyPs, and all the active site residues are
conserved. The enzymatic activity of Asp f 11 was dem-
onstrated by its ability to catalyze the cis-trans isomeri-
zation of N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide
(Flu¨ckiger et al., 2002). The human CyPA-Ala-Pro com-
plex was obtained by soaking native crystals in 100
mM Ala-Pro (Ke et al., 1993a). A Kd of 23.3 mM was mea-
sured for Ala-Pro withCaenorhabditis elegansCyP3 (Wu
Sy et al., 2001). Therefore, at a concentration of 80 mM
Ala-Pro, one would expect binding of the dipeptide to
Asp f 11. This is probably true for the monomeric form.
Overall Structure
The intertwined chains A and B form two similar sub-
units. Subunit A consists of the N-terminal amino acids
1–69 and the C-terminal amino acids 128–171 of chain
A plus the domain-swapped residues 96–127 of chain
B. Subunit B consists of the N-terminal amino acids 1–
68 and the C-terminal amino acids 128–171 of chain B
plus the domain-swapped residues 92–127 of chain A
(Figures 1A and 1B). As in all other cyclophilins, the
fold of each subunit consists of an eight-stranded anti-
parallel b barrel, and two a helices covering the top
and the bottom of the barrel. In subunit A, there is an ad-
ditional small 310 helix formed by Thr122, Ser123, and
Trp124 of chain B. In subunit B, Arg93 to Lys97 of chain
A adopt an a-helical conformation, whereas in subunit A
and in all other structurally known cyclophilins, this
stretch is coiled.
Superposing human CyPA on either subunit of Asp f
11 reveals some structural deviation (Figure 1C). The
rmsd between the Ca positions of subunit A and CyPA
is 1.18 A˚, using a cut-off distance of 3.5 A˚ (120 out of
128 alignable pairs). For subunit B the corresponding
rmsd is 1.26 A˚ (120 out of 130 alignable pairs). There is
also some deviation between subunit A and B—mainly
in the domain-swapped part—as shown by the rmsd
of 1.15 A˚ (no cut-off). Using a 3.5 A˚ cut-off, the rmsd be-
tween 130 out of 135 alignable pairs drops to 0.65 A˚.
Compared to human CyPA, there are some structural
differences due to residue inserts (see sequence align-
ment, Figure 2). One difference in sequence and struc-
ture is the prolongation of the first loop after the first
b strand by 5 residues. Another insert of two amino acids
(Glu138/Lys139) leads to the elongation of helix 2, and
a third insert (Asn160/Thr161) prolongs the loop after he-
lix 2 (Figure 1C).
A further structural deviation is found in the loop after
the first a helix (R45-PAG-E49), a divergent loop, where
some CyPs have an insert (e.g., C. elegans CyP3
[Dornan et al., 1999]). Compared to human CyPA and
CyPB, which feature the sequence GEKGF in the corre-
sponding region, and form a type I b turn, the turn of Asp
f 11 swings into the opposite direction, forming a type II
b turn (Figure 1C). The same conformation has been ob-
served in the structure of C. elegans CyP5 (Picken et al.,
2002), featuring a similar sequence (KPKGE) as Asp f 11.The protein forms a disulfide bond between Cys43 of
the N terminus and Cys168 near the C terminus. The cys-
teines oxidize very slowly over time. This results in a pro-
tein, which is half oxidized and half reduced after purifi-
cation and storage at 4ºC for several days. Treatment
with oxidized glutathione has no effect, probably due
to the inaccessibility of the cysteines. The electron den-
sity reflects the situation very well. About 50% of the
cysteines are visible in their reduced and 50% in their
oxidized form. The sulfur atoms of the reduced cyste-
ines are separated by 4.58 A˚ and 4.49 A˚ in subunit A
and B, respectively. Simple rotation about the Ca-Cb
cysteine side chain bonds toward each other allows di-
sulfide bond formation with a bond length of 2.04 A˚ and
chi torsion angles around 180º for all oxidized cysteines
in both subunits. In the electron density, no disorder or
conformational change is observed in the proximity of
the disulfide bonds. Potential roles of this disulfide
bond could be the stabilization of the protein in an
oxidizing environment or a signaling mechanism in
response to oxidative stress, as hypothesized for C.
elegans CyP3 (Dornan et al., 1999). Both cysteines are
conserved in many cyclophilins (Figure 2).
3D Domain Swapping
A striking feature is the dimerization of the protein by 3D
domain swapping. A central segment—the end of the
first hinge loop (aa 92–99 in chain A, aa 96–99 in B), the
fifth and sixth b strand (aa 100–118) and the subsequent
loop (aa 119–127)—changes into the neighboring sub-
unit, thus displacing its corresponding element (Figures
1A and 1B).
3D domain swapping is quite rare. To date, about 60
structures of domain-swapped proteins have been re-
ported, most of them exchanging their N or C terminus
(Liu and Eisenberg, 2002). Only few proteins are known
to swap a central element. For example, blood coagu-
lant factor IX/X binding protein, an anticoagulant iso-
lated from the venom of the habu snake, consists of
two homologous subunits linked by an intermolecular
disulfide bond. The two subunits form a heterodimer
by exchanging a loop in the central part of the molecule
(Mizuno et al., 1997). The NC1 Domain of type IV colla-
gen forms a heterotrimer consisting of two a1 chains
and one a2 chain, involving domain swapping of two
central b strands (Sundaramoorthy et al., 2002). The
structure of Asp f 11 reported here also exchanges
a central element, but forms a homodimer. Because mo-
nomeric nonswapping structures of homologous CyPs
are known, and because the swapped domain in Asp f
11 adopts exactly the same conformation as the corre-
sponding nonswapped domain in homologous struc-
tures, this kind of domain swapping is termed quasi-
domain swapping (Liu and Eisenberg, 2002). To our
knowledge, Asp f 11 is the only quasi-domain-swapped
homodimer exchanging a central element.
This kind of 3D domain swapping requires two hinge
loops that adopt a different conformation in the do-
main-swapped dimer and in the monomer. The second
hinge loop is very short in Asp f 11. It runs from amino
acid 126 to 129 (DGKH) and adopts a different confor-
mation in each chain. All backbone atoms of this hinge
loop and the side chains of the aspartate and the histi-
dine are clearly defined in the experimental electron
Structure
188Figure 1. Crystal Structure of Asp f 11
(A) Overall structure of the 3D domain-
swapped Asp f 11 dimer. Chain A and B are
in red and blue, respectively. The conserved
Trp124 is shown as capped stick model.
(B) Topology plot of secondary structure ele-
ments of the dimer schematically showing
the 3D domain swapping.
(C) Superposition of two independent mono-
mers of human CyPA (2CPL)—one in green,
one in yellow—on subunit A (core in red,
swapped domain in blue) and on subunit B
(core in blue, swapped domain in red) of
Asp f 11, respectively. The view is the same
as in (A), but rotated by 90º perpendicular to
the plane. The moieties of the protein diverg-
ing from human CyPA have been numbered
from 1 to 8. The conformation of Trp124 of
Asp f 11 is different from Trp121 of human
CyPA (1). The end of the first hinge loop is
a-helical in chain A of Asp f 11, whereas it is
coiled in human CyPA (2). The divergent
loop of Asp f 11 forms a type II b turn, whereas
in CyPA it forms a type I b turn (3). The first
loop is prolongated in Asp f 11 (4). Helix 2 is
prolongated in Asp f 11 by 2 residues (5).
The loop after helix 2 is elongated by another
2 residues (6). The side chain carboxyl of
Glu86 of human CyPA (homologous to
Glu89 of Asp f 11) superposes on the sulfate
ion in the Asp f 11 crystal structure (7). Asp f
11 forms a disulfide bond, human CyPA
doesn’t (8).density, whereas the side chain of the lysine is not visible
(Figure 3A). All distances, angles, and torsions in the
hinge loop are chemically sound with torsion angles lying
in the most favored or additional allowed regions of the
Ramachandran plot. There are three H bonds between
the hinge loops of chain A and B (A:His129;N bonded
with B:Leu125;O, A:Leu125;O with B:His129;NE2, and
A:Gly127;N with B:Trp124;O). An additional H bond is
formed within the hinge loop of chain A (Trp124;O with
His129;NE2) (Figure 3A).The first hinge loop is very long, running from amino
acid 68 to 99. In homologous structures, this part is
very well defined. It forms a long loop, which runs like
a handle from one side of the molecule to the other
side, connecting b strands 4 and 5. In contrast, the larger
part of this loop is disordered in Asp f 11 and thus not
visible in the electron density. Therefore, its role as hinge
loop is ambiguous. Nevertheless, the electron density
implies that this loop must be arranged in a different
way than in homologous structures. First, a well-defined
Crystal Structure of A. fumigatus Cyclophilin
189Figure 2. Structure-Based Sequence Alignment of Asp F 11 with Homologous CyPs
The top line shows the secondary structure of Asp f 11 assigned by DSSP (Kabsch and Sander, 1983). The 310-helix formed by chain B (Thr122–
Trp124) and the additional a helix 20 formed by chain A (Arg93–Lys97) are not indicated. The second line shows the sequence numbering of Asp f
11. A ‘‘plus’’ sign at the N terminus indicates truncation of the signal sequence. The first and second hinge loop of Asp f 11 are underlined, and the
W loop is in bold. The divergent loop (aa 45–49) is in italics. The aligned CyPs are human CyPA (PDB code 2CPL), human CyPB (1CYN),C. elegans
CyP3 (1DYW), C. elegans CyP5 (1H0P), S. cerevisiae CyPA (1IST), and P. falciparum CyP19 (1QNG) (Table 1).sulfate ion is positioned on top of a helix 1 beside the
pyrrolidine ring of Pro33, where—in homologous struc-
tures—the side chain carboxyl of Glu89 is situated
(Figure 1C). This implies that Glu89 of the long loop of
Asp f 11 is differently positioned. Both residues, Pro33
and Glu89, are highly conserved in all CyPs (Figure 2).Second, the visible end of the long loop of Asp f 11
adopts a different conformation from the corresponding
loops of homologous structures (Figure 1C). Going
backward from b strand 5, this part of the loop folds
back in homologous CyPs, running toward b strand 4
within the same subunit. In Asp f 11, this part of theFigure 3. W Loop Bound to Active Site and
Second Hinge Loop
(A) Electron density of the second hinge loop
and parts of the adjacent W loop (aa 124–
129). The experimental map is contoured at
1s using solvent-flattened experimental
phases calculated without NCS averaging.
H bonds within and between the hinges of
both chains are indicated by yellow, dashed
lines. Residues of chain A and B are colored
in violet and green, respectively.
(B) Hydrophobic binding of the W loop into its
own active site. Trp124 and Leu125 of chain A
sit into the hydrophobic pocket of subunit A,
making hydrophobic interactions with sur-
rounding residues of both chains. In subunit
B, Val121 and Trp124 of chain B sit into its ac-
tive site. Position and conformation of some
distinctive residues of human CyPA (2CPL)
are shown for comparison. Two independent
monomers of CyPA were superimposed on
either subunit of Asp f 11 (see Figure 1C).
Side chains of CyPA superposed on subunit
A and B are colored in orange and yellow, re-
spectively.
Structure
190Figure 4. Illustrations of Putative Forms of 3D Domain Swapping
The first hinge loop, which is not visible in the crystal structure, is in dashes. The second hinge loop is fully drawn.
(A–E) (A) 3D domain swapping of the central element, as proposed in the crystal structure, leads to intramolecular disulfide bonds (shown in yel-
low). (B) 3D domain swapping of the C terminus would lead to intermolecular disulfide bonds; this case can be ruled out for the crystal structure
by a nonreducing SDS-PAGE (Figure 5). (B–E) C-terminal (B) and N-terminal domain swapping (C) can lead to misfolded dimers, which are
covalently linked by intermolecular disulfide bonds. A combination of central, C-terminal and N-terminal domain swapping can lead to covalently
linked trimers (D) and tetramers (E).loop goes straight on, pointing toward b strand 4 of
the neighboring subunit. It forms an a helix in chain A
(aa 93–97), whereas, in chain B, it adopts a rather ex-
tended conformation (aa 96–99).
Nevertheless, the missing electron density leads to two
putative scenarios in respect to domain swapping. First,
this long loop represents a hinge loop, thus swapping—
togetherwith the secondhinge loop—thecentral element,
as suggested in this work (Figure 4A). Second, this loop
doesn’t represent a hinge loop. Thus, the remaining sec-
ond hinge loop would domain-swap the whole C terminus
(aa 128–171) (Figure 4B) instead of the central element.
Taking distances and crystal packing into account, both
cases would be possible:b strand 4 connected tob strand
5 of the neighboring subunit or to b strand 5 of the same
subunit. In the first case, we end up with an intramolecular
disulfide bond (Cys43-Cys168) between the N and the C
terminus, as shown in Figure 4A. The second case would
lead to an intermolecular disulfide bond (Figure 4B). This
second case can be ruled out easily by a denaturing, non-
reducing SDS-PAGE. Figure 5 shows that the crystallized
protein runs as two very close bands, both at the height of
the monomer and both with about the same intensity. The
lower band represents reduced protein, the upper band
oxidized protein containing an intramolecular disulfide
bond. This finding reflects the situation in the electron
density, where 50% of the cysteines are reduced and
50% oxidized. The disulfide bonding is intramolecular,
connecting the N and C terminus within the same chain.
Therefore, the long loop must represent a hinge loop,
swapping—together with the second hinge loop—the
central element. Interestingly, both regions depicted
here as hinge regions are conserved in length and se-
quence between the homologous proteins (Figure 2), sug-
gesting that domain swapping could also occur in other
CyPs. The structural analysis clearly shows that 3D do-
main swapping is the only solution, allowing fitting of
the electron density map and structural refinement.
Thus, a similar dimerization arrangement would be ex-
pected for homologous proteins undergoing the same
event, while for the structures showing the monomeric
state (Table 1), different crystal packing arrangements
have been observed.
There is one other small loop not visible in the electron
density, connecting b strands 5 and 6 (aa 105–112). Buthere—considering distances—the connectivity is unam-
biguous.
Dimer Interface and Binding of W Loop
into Active Site
Asp f 11 dimerizes by 3D domain swapping, which leads
to a highly intertwined molecule. The calculated surface
area of the interface between chain A and B is 2310 A˚2
per monomer, which makes up about one fourth of the
whole surface area of chain A (8880 A˚2). The interface
formed by purely nonswapped parts—excluding hinges
Figure 5. Reducing and Nonreducing SDS-PAGE of Crystallized and
Misfolded Asp f 11 Protein
Molecular weights of the marker proteins (lane 3) are indicated on
the left side. The shown lanes correspond to: crystallized protein
under reducing (lane 5) and nonreducing (lane 7) condition. As a con-
trol, protein before crystallization under reducing (lane 4) and non-
reducing (lane 6) condition, each 3 mg. Misfolded protein under non-
reducing conditions at 4 mg (lane 8), 8 mg (lane 9), and 16 mg (lane 10).
As a control, misfolded protein under reducing conditions, 8 mg
(lane 1). Reduced protein is shown as a reference (lane 2). Under
nonreducing conditions, the upper band around the 21.5 kDa marker
represents the oxidized form of the protein, whereas the lower band
indicates the reduced one. The small difference in running behavior
between reducing and nonreducing condition is due to the presence
or absence of DTT/ b-mercaptoethanol as shown by the analysis of
partially reduced batches of protein (data not shown).
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than 8% of the whole interface). Thus, most interactions
in the dimer interface are contributed by either of the
swapped domains.
The swapped b strands 5 and 6 replace the corre-
sponding elements in the neighboring subunit, adopting
exactly the same conformation (Figure 1C). Together
with b strands 3 and 4, they form the hydrophobic
pocket where the active site for the cis-trans isomeriza-
tion function is situated. The subsequent domain-swap-
ped loop (aa 119–125) contains a highly conserved tryp-
tophan (W124), and is thus called the W loop. It also
replaces the corresponding W loop in the neighboring
subunit, but, in this way, comes to lie in its own active
site. This additional intramolecular interaction is not ob-
served in other CyPs. The conformation of the two cor-
responding W loops compared to each other and to
the homologous W loop in human CyPA is not identical,
but similar (Figure 1C).
The binding mode of the W loop within the active site
is different in each subunit of Asp f 11. In subunit A, the
side chains of Trp124 and Leu125 of chain A make hy-
drophobic interactions with the side chains of Ile60,
Phe63, Met64, and His129 of chain A and with the do-
main-swapped side chains of Phe116, Thr118, Val121,
Trp124, and Leu125 of chain B (Figure 3B). In subunit
B, the side chains of Trp124 and Val121 of chain B
make hydrophobic interactions with the side chains of
residues Phe63, Met64, and His129 of chain B and
Phe63, Ser102, Ala104, Phe116, Thr118, Thr122, and
Leu125 of chain A (Figure 3B). Interestingly, the position
and orientation of the side chain of Trp124 are different
in the two subunits. In subunit B, the benzene ring of
Trp124 makes p-p interactions with the imidazole ring
of His129, while in subunit A, it only makes van der Waals
interactions.
The side chains of the W loop, which interact with the
active site (Trp and Leu in chain A, Trp and Val in chain B)
are completely buried in Asp f 11. In homologous struc-
tures, these residues lie on the rim of the active site, and
the side chains of the tryptophan and the valine are sol-
vent accessible.
The binding of Trp and Leu/Val within the active site of
Asp f 11 leads to a change in the side chain conformation
and/or in the position of the Ca atom of all the residues
involved in the hydrophobic pocket when compared to
superposed human CyPA. The most distinctive dis-
placements include the Ca positions of A:Phe63 (2.0
A˚), B:Phe63 (2.2 A˚), B:Val121 (2.6 A˚), A:Trp124 (3.0 A˚),
and the side chain positions of A:Phe116;CZ (5.2 A˚),
B:Phe116;CZ (5.2 A˚), and B:His129;CH2 (5.4 A˚), to
name but a few (Figure 3B). These findings explain the
relatively high rmsd between the human CyPA and the
chain A and B of Asp f 11 (see above).
Biological Relevance
Is the domain-swapped Asp f 11 dimer physiologically
relevant, or is it just a crystallographic artifact? For do-
main-swapped proteins in general, both cases have
been reported (Liu and Eisenberg, 2002). Domain swap-
ping was originally proposed to be a mechanism for the
emergence of oligomeric proteins and as a means of
functional regulation (Bennett et al., 1995). It can also
be a potentially harmful process leading to misfolding,aggregation, and amyloid formation of some proteins
(e.g., cystatin C [Janowski et al., 2001; Staniforth et al.,
2001] and human prion protein [Knaus et al., 2001]). Sev-
eral artifacts of domain-swapped proteins have been re-
ported, where the biological function for the dimers are
unknown (Liu and Eisenberg, 2002). They were obtained
under nonphysiological low pH, and, often, the domain
swapping only occurred as a consequence of the trun-
cation of the whole protein.
The Asp f 11 crystals were grown under physiological
pH, but under nonphysiological high salt and high pro-
tein concentrations. Despite these facts, dimerization
cannot be excluded in vivo due to effects like local con-
centration, other binding partners, or macromolecular
crowding in cells (Minton, 2001). Binding of other mole-
cules to Asp f 11 or an environmental change could in-
duce domain swapping and dimer formation. The effect
of other macromolecules on a specific macromolecule
in cells has been studied and termed macromolecular
crowding (Minton, 2001). Macromolecular crowding in-
creases local protein concentration and facilitates pro-
tein oligomerization (Lindner and Ralston, 1995; Rivas
et al., 1999).
In vitro, the Asp f 11 protein is clearly monomeric un-
der physiological conditions, even at high protein con-
centration, as shown by gel filtration (Figure 6A). The
protein elutes at 12.55 ml, forming one single peak. Cal-
ibration with marker proteins yields a molecular weight
of 14.9 kDa, which is in agreement with the calculated
monomer weight of 18.9 kDa. Under these conditions,
the protein also shows cis-trans isomerization activity
(Flu¨ckiger et al., 2002).
However, dimerization can be induced in solution with
a modified crystallization buffer at an ammonium sulfate
concentration of 20% (Figure 6B). Besides the monomer
peak, a second peak, corresponding to a dimer, is ob-
tained. The height of the second peak is dependent on
the concentration of the protein. The higher the protein
concentration, the bigger the fraction of the dimeric
form. Gel filtration of protein at 7.5 mg/ml results in a di-
mer fraction of about 10%. Both peaks exhibit shoul-
ders, which might represent reequilibrating protein or in-
termediate states, such as partly unfolded protein. To
assess the peptidylprolyl cis-trans isomerase activity
of the monomeric and dimeric fraction of the gel filtration
experiment performed with modified crystallization
buffer, enzymatic activity was measured with the assay
described by Kofron (Kofron et al., 1991). The enzymatic
assay clearly shows that the dimer fraction is inactive
while the monomer fraction is active (Figure 6D). This in-
dicates that the dimer observed in the gel filtration ex-
periment is arranged in a similar way as the dimer seen
in the crystal structure. Furthermore, it implies a putative
regulation mechanism.
In general, CyPs are active in their monomeric form.
No dimerization, and thus no potential role for this hypo-
thetical state, have been reported to date. For Asp f 11,
both the monomer and the dimer form can be demon-
strated (Figures 6A and 6B). Dimerization, as shown by
the crystal structure, obviously inactivates the cis-trans
isomerization function, since both active sites are occu-
pied by their own W loops. Therefore, dimerization of
Asp f 11 in vivo could be a means of regulating its own
biological function.
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folded Asp F 11 Protein and Peptidylprolyl
cis-trans Isomerase Activity of the Mono-
meric and Dimeric Fraction
(A) Protein at 2 mg/ml (bold line) and 7.5 mg/
ml (thin line) under physiological conditions
(100 mM NaCl, 50 mM Tris, pH 7.5); the chro-
matogram shows only a monomer peak,
which elutes at 12.55 ml. Calibration with
four marker proteins yields a molecular
weight of 14.9 kDa (R2 = 0.98).
(B) Protein at 2 mg/ml (bold line) and 7.5 mg/
ml (thin line) in a modified crystallization
buffer (20% ammonium sulfate, 0.1 M MES,
pH 6); the chromatogram shows an addi-
tional, smaller dimer peak, which is concen-
tration dependent. The main fraction elutes
at 13.77 ml, whereas the second peak elutes
at 10.68 ml. The high salt conditions used
cause the observed shift in the elution times.
Despite a low correlation factor (R2 = 0.94),
calibration with the four marker proteins indi-
cates a monomeric state for the major peak
and a dimeric state for the minor peak.
(C) Misfolded protein at 2 mg/ml under phys-
iological condition (100 mM NaCl, 50 mM Tris,
pH 7.5). The major peak elutes at 12.5 ml cor-
responding to the monomeric state. The mi-
nor peak, the shoulder to the right, and the
shoulder to the left elute at 10.05, 10.30, and
9.31 ml, which results in calibrated weights
of 34.2, 31.5, and 43.7 kDa, respectively,
indicating at least the formation of dimers
and possibly a trimer.
(D) Peptidylprolyl cis-trans isomerization by monomeric (bold line) and dimeric (normal line) Asp f 11 and, as a negative control, in the absence of
protein (thin line). The substrate N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide was isomerized, the trans-isomer was cleaved by a-chymotrypsin,
and the increase in absorbance measured at 390 nm. The monomer fraction is active, whereas the dimer fraction is inactive.Misfolding
Two flexible hinge loops could leave the protein prone to
misfolding. 3D domain swapping can be a harmful
mechanism for misfolding, aggregation, and amyloid
formation (Rousseau et al., 2003).
Indeed, misfolding of Asp f 11 can be induced by
freeze-thawing the protein in its reduced form. Freeze-
thawing of oxidized protein does not lead to unfolding
and refolding/misfolding, probably due to the stabiliza-
tion of the protein by the intramolecular disulfide bond.
After freeze-thawing, about 30% of the reduced protein
precipitated. The remaining soluble part was changed
into a nonreducing buffer, in order to allow oxidation.
A subsequent gel filtration under physiological condi-
tions clearly showed absorption peaks in the dimer to
tetramer range, in addition to the monomer peak
(Figure 6C). Analysis of the gel filtration fractions by non-
reducing SDS-PAGE shows monomers as well as cova-
lently linked dimers, trimers and tetramers (data not
shown). The ratio between the peak heights was inde-
pendent of the protein concentration; the oligomer
peaks also appear at low concentration (data not
shown). The protein used for gel filtration was analyzed
by a nonreducing, denaturing SDS-PAGE (Figure 5).
Again, the gel showed two close bands at the mono-
meric weight, which correspond to nonoxidized and to
intramolecularly oxidized protein. Moreover, there are
bands visible at the dimer, trimer, tetramer, and at higher
oligomer masses. These bands must represent oligo-
mers covalently linked by intermolecular disulfidebonds. They disappear under reducing conditions (Fig-
ure 5, lane 1), as expected for oligomers formed by inter-
molecular disulfide bonds. These results suggest that
partial unfolding and refolding occurs during freeze-
thawing under reducing conditions.
The observed covalently linked multimers can be ex-
plained by alternative forms of 3D domain swapping.
The protein can refold/misfold into a dimer, where the
whole C terminus after the second hinge loop or the
whole N terminus before the first hinge loop is domain
swapped (Figures 4B and 4C). These two kinds of do-
main swapping only involve one hinge loop each. After
oxidation, the two chains of the dimer will be covalently
linked. A combination of N-terminal, C-terminal, and/or
central domain swapping can lead to linear trimers and
tetramers (Figures 4D and 4E), and also to cyclic tetra-
mers. Linear multimerization could carry on to higher
oligomers, aggregates, and, eventually, precipitate,
which indeed can be observed in vitro after freeze-thaw-
ing. Therefore, incorrect 3D domain swapping could
serve as a model for the mechanism of misfolding and
precipitation of proteins in general.
Another explanation for the covalently linked multi-
mers could be unspecific disulfide bonding between in-
dependent, nonswapping subunits, but this seems very
unlikely. There are only two cysteines in Asp f 11 that can
form the aforementioned disulfide bond. Both cysteines
are involved in secondary structure elements. Cys43 is
situated in a helix 1, Cys168 in b sheet 8. This makes
the whole region more rigid, despite the fact that
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completely inaccessible by solvent as calculated by
NACCESS (Hubbard and Thornton, 1996), both in the re-
duced and the oxidized form. During freeze-thawing un-
der reducing conditions, neither a specific nor a nonspe-
cific disulfide bond can form. Once the protein is
refolded and after the buffer is exchanged against a non-
reducing buffer, disulfide bonding is more likely to occur
within the same subunit, due to solvent inaccessibility of
the cysteines.
One wonders, why nature preserves features such as
two flexible hinge loops and—as observed in all other
CyP structures—a solvent-accessible tryptophan,
which leave the protein highly prone to misfolding. The
two hinges, as well as the tryptophan and the leucine
of the W loop are highly conserved among all CyPs (Fig-
ure 2). This leads to the assumption that the domain-
swapped protein, as observed in the present crystal
structure, could have a biological meaning, but its bio-
logical role has yet to be found. Further work could focus
on the characterization of the different misfolded multi-
mers and on homologous CyPs in order to investigate
whether they show the same multimerization behavior
as that of Asp f 11.
Experimental Procedures
Cloning, Protein Expression, and Purification
The original full-length CyP from A. fumigatus was cloned by phage
surface display (Crameri et al., 1994) as N-terminal, noncleavable
His-tagged protein containing a linker of 9 amino acids between
the His tag and the start methionine (Crameri, 1999). In order to clone
a thrombin-cleavable His-tagged protein, the Asp f 11 gene was am-
plified from the original clone by PCR with the primers 50 BamHI-1
50-CCGCGGATCCATGTCTCAGGTCTTCTTC-30 and 30 HindIII-1 50-
GCCCAAGCTTTTACAGCTCACCACAGTTGAC-30 by Deep Vent
Polymerase (NEB, Beverly, MA). The PCR product was digested
with BamHI and HindIII restriction endonucleases (NEB), cleaned
with QIAquick PCR purification kit (Qiagen, Hilden, Germany), and li-
gated into a modified pQE32 vector containing an N-terminal His6
tag followed by a thrombin cleavage site (HHHHHHLVPRGS), where
GS corresponds to the BamHI site. The recombinant vector was
transformed into Escherichia coli strain XL1-Blue and the sequence
of the insert verified by DNA sequencing.
The XL1-Blue cells were grown at 37ºC in LB medium to an OD600
of 0.6, induced with 1 mM IPTG, harvested after another 15 hr of in-
cubation by centrifugation at 60003 g for 10 min at 4ºC, and stored
at 220ºC. The cell pellet was resuspended in lysis buffer (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by
French press. The insoluble material was removed by centrifugation
at 20,000 3 g (20 min, 4ºC).
The His-tagged recombinant protein was purified by nickel affinity
chromatography with a 5 ml HiTrap Chelating HP column (Amer-
sham Pharmacia Biotech, Uppsala, Sweden). The protein was eluted
in a linear buffer gradient (10–250 mM imidazole, 50 mM NaH2PO4,
300 mM NaCl, pH 8.0). The N-terminal His tag was cleaved off by
thrombin (20 U/mg protein) in 300 mM NaCl, 50 mM Tris, 2 mM
CaCl2, pH 7.5, by incubation for 18 hr at 22ºC. The cleaved protein
was further purified by gel filtration on a Superdex 75 column
(FPLC, Pharmacia, Uppsala, Sweden) equilibrated with 100 mM
NaCl, 50 mM Tris, pH 7.5. The eluted protein was diluted 1:10 with
H2O and concentrated to 16 mg/ml. Protein identity and purity
were assessed using MALDI-TOF mass spectroscopy and SDS-
PAGE.
The selenomethionine-substituted protein was expressed under
minimal media conditions that inhibit methionine synthesis (Van
Duyne et al., 1993). The XL1-Blue cells were incubated overnight in
LB medium at 37ºC and harvested at 60003 g for 10 min. The pellet
was washed twice in H2O and then inoculated into 1 liter M9 medium
(supplemented with the appropriate antibiotics, 1 mM MgSO4, 0.4%glucose, 0.00005% thiamine, 100 mg Lys, Phe, and Thr each, and 50
mg Ile, Leu, Val, and SeMet each) at 37ºC until an OD600 of 0.45 was
reached. After induction with 1 mM IPTG, the cells were grown at
37ºC for another 15 hr. The SeMet protein was purified and throm-
bin-digested by the same procedure as the native protein, except
that all buffers were supplied with 10 mM b-mercaptoethanol. The
digested SeMet protein was further purified by gel filtration on
a Superdex 75 column (FPLC, Pharmacia) equilibrated with 100
mM NaCl, 50 mM Tris, 10 mM DTT, pH 7.5. The eluted protein was
diluted 1:10 with H2O, 10 mM DTT, and concentrated to 9 mg/ml.
The incorporation of SeMet was verified by MALDI-TOF mass spec-
troscopy.
Crystallization
Crystallization was performed with the hanging drop vapor diffusion
method at 23ºC. The protein was crystallized by mixing 3 ml of pro-
tein solution (7 mg/ml with or without 80 mM Ala-Pro) with an equal
volume of crystallization solution (13% ammonium sulfate, 0.1 M
MES, pH 6), equilibrating it against 500 ml of reservoir solution
(50% ammonium sulfate, 0.1 M sodium citrate, pH 5.5). Crystals
grew to a size of 300 3 300 3 150 mm within 3–5 days. They belong
to space group P3121, with cell parameters a = b = 64.8 A˚, c = 156.3
A˚, and contain two monomers per asymmetric unit.
The selenomethionylated protein crystals were obtained under
the same conditions, adding 80 mM Ala-Pro to the protein solution
and 5 mM DTT to the reservoir solution. They grew to 200 3 140 3
140 mm, and belong also to space group P3121, with cell parameters
a = b = 64.9 A˚, c = 157.0 A˚. Crystals were cryoprotected by soaking
them stepwise for 20 s in reservoir solution complemented with 80
mM Ala-Pro, increasing the ethylene glycol concentration from 6%
to 12% and then 19%. The crystals were flash-cooled in a stream
of gaseous nitrogen and measured at 100 K.
Data Collection, Phasing, and Refinement
Data were obtained on the synchrotron beamline X06SA at Swiss
Light Source (Villigen, Switzerland). A dataset of a native crystal
was collected to 1.85 A˚ resolution (Table 2). MAD data were col-
lected with a selenomethionylated crystal to a resolution of 2.05 A˚
in order to determine the structure by the MAD technique (Table 2).
Data were processed and scaled with DENZO and SCALEPACK of
the HKL program package (Otwinowski and Minor, 1997). The sele-
nium atom positions were found with SHELXD (Schneider and Shel-
drick, 2002) with MAD FA values calculated with XPREP (Bruker Non-
ius). Experimental phases were calculated and refined with SHARP
(de La Fortelle and Bricogne, 1997). The initial electron density
was improved by solvent flattening with 2-fold NCS averaging using
RESOLVE (Terwilliger, 1999). A polyalanine model of human CyPA,
Protein Data Bank (PDB) code 2CPL (Ke, 1992) was fit into the im-
proved electron density by phased molecular replacement using
MOLREP (Vagin and Teplyakov, 1997), followed by manual rebuild-
ing using XtalView (McRee, 1999). The structure was refined against
the native dataset with REFMAC (Murshudov et al., 1997) as imple-
mented in the CCP4 program suite (CCP4, 1994). Initially, NCS re-
straints were used, which were stepwise released and finally omit-
ted. Water molecules were introduced using ARP (Lamzin and
Wilson, 1993). Final rounds of refinement were carried out with
TLS refinement, defining the domain-swapped central element and
the N terminus before, together with the C terminus thereafter, of
each chain as separate TLS groups. Statistics from phasing and re-
finement are provided in Table 2. The stereochemical quality of the
final model was assessed with PROCHECK (Laskowski et al.,
1993) and WHATCHECK (Hooft et al., 1996). Secondary structure
elements were assigned automatically with DSSP (Kabsch and
Sander, 1983). Surface areas were calculated with the program
NACCESS (Hubbard and Thornton, 1996), an implementation of
the Lee and Richards solvent accessibility algorithm (Lee and
Richards, 1971), with a probe radius of 1.4 A˚ and a slice width of
0.01 A˚. In order to obtain a good experimental map of the hinge re-
gions (aa 126–129) between the two subunits, solvent flattening was
redone without NCS averaging. The resulting electron density map
(Figure 3) makes tracing unambiguous. Building of the model in
a nonswapped way was not feasible with this experimental map.
To assess the correctness of the tracing of the hinge region,
a real-space map correlation was calculated by overlapmap
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correlation coefficients higher than 0.7 in the main chain of the con-
necting loops as well as the rest of the protein.
Characterization of Quaternary Structure and Activity Assay
The molecular weight of the Asp f 11 protein in solution was deter-
mined by gel filtration on a Superdex 75 column (Pharmacia), equil-
ibrated in 100 mM NaCl, 50 mM Tris, pH 7.5. A total of 100 ml of pro-
tein at two different concentrations (2.0 and 7.5 mg/ml) were eluted
with the same buffer at a flow rate of 0.8 ml/min at 23ºC. Aprotinin,
cytochrome C, carbonic anhydrase, and BSA (molecular weight
marker kit; Sigma, St. Louis, MO) served as marker proteins.
Dimerization behavior was studied in a modified crystallization
buffer (20% ammonium sulfate, 100 mM MES, pH 6) with the same
column and the same parameters. The protein (at two different con-
centrations: 2 and 7.5 mg/ml) was incubated in the modified crystal-
lization buffer for 3 hr at RT before application.
Oligomerization behavior of misfolded protein was studied in 100
mM NaCl, 50 mM Tris, pH 7.5, with the same column and parame-
ters. Misfolding was induced by freeze-thawing. The protein was pu-
rified under reducing conditions (as described above) and frozen at
220ºC in 100 mM NaCl, 50 mM Tris, 10 mM DTT, pH 7.5. After thaw-
ing at RT, the precipitated part (about 30%) was removed by centri-
fugation at 15,0003 g, 5 min, 4ºC, and the buffer exchanged against
a nonreducing buffer (100 mM NaCl, 50 mM Tris, pH 7.5). The protein
was applied on the column at 2 mg/ml.
The nature of intra- or intermolecular disulfide bonding of protein,
which was used for gel filtration and crystallization, as well as crys-
tallized protein, which was dissolved in H2O, was analyzed by reduc-
ing and nonreducing SDS-PAGE with 15% polyacrylamide gels. For
reducing SDS-PAGE, the samples were mixed with 33 SDS sample
buffer, supplemented with 10% (v/v) b-mercaptoethanol and 0.5 M
DTT, and boiled at 95ºC for 20 min. For nonreducing SDS-PAGE,
samples were mixed with 33 SDS sample buffer containing no re-
ducing agents.
Peptidylprolyl cis-trans isomerase activity of the monomeric and
dimeric fraction of the gel filtration experiment with modified crystal-
lization buffer was measured by the assay described by Kofron (Ko-
fron et al., 1991) with minor modifications. A total of 25 ml of 0.5 mM
protein solution (final concentration, 25 nM) were diluted with 437.5
ml 50 mM HEPES, 100 mM NaCl, pH 8 (all solutions cooled on ice).
Then, 25 ml of 10 mg/ml a-chymotrypsin (Sigma) in 1 mM HCl was
added and the reaction was started by adding this mixture to 12.5
ml of 4 mM N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide (Sigma) in tri-
fluoroethanol, 470 mM lithium chloride, in a semimicrocuvette. The
increase in absorbance at 390 nm was measured for 3 min at 0ºC
in a Cary 50 Conc spectrophotometer. The background, which is
due to thermal cis-trans isomerization of the substrate, was mea-
sured with a blank sample without protein.
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